White Papers

Optimizing Oncology Outcomes: The Impact of Pharmacist-Led Clinical Interventions 70 70 Shields Health Solutions

Optimizing Oncology Outcomes: The Impact of Pharmacist-Led Clinical Interventions

Cancer care is complex. For patients prescribed oral oncolytics, managing side effects, staying on schedule, and coordinating care can be overwhelming. These challenges often lead to missed doses, therapy interruptions,…

The Role of Health System Specialty Pharmacy in Cardiometabolic Disease Care 70 70 Shields Health Solutions

The Role of Health System Specialty Pharmacy in Cardiometabolic Disease Care

Unlock Better Outcomes in Cardiometabolic Disease Care Cardiometabolic disease (CMD) is one of the most pressing healthcare challenges of our time—driving trillions in costs and impacting millions of lives. From diabetes…

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy 70 70 Shields Health Solutions

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy

  According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…

How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients 204 115 Shields Health Solutions

How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Exploring AI’s Potential to Transform Specialty Pharmacy 204 115 Shields Health Solutions

Exploring AI’s Potential to Transform Specialty Pharmacy
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
The Impact of Specialty Pharmacy on Clinician Utilization 204 115 Shields Health Solutions

The Impact of Specialty Pharmacy on Clinician Utilization
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
Pediatric Patients Benefit from An Integrated Specialty Pharmacy Care Model 204 115 Shields Health Solutions

Pediatric Patients Benefit from An Integrated Specialty Pharmacy Care Model
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology 204 115 Shields Health Solutions

The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology
This white paper describes how an integrated specialty pharmacy can help alleviate the burden on health systems and their patients.
How Specialty Pharmacy Can Support Value-Based Care and Population Health 204 115 Shields Health Solutions

How Specialty Pharmacy Can Support Value-Based Care and Population Health
This white paper discusses how expanding integrated health system specialty pharmacy can be an impactful tool that health systems can leverage to improve their performance under value-based care contracts.
How Specialty Pharmacy Can Address and Impact Social Determinants of Health 204 115 Shields Health Solutions

How Specialty Pharmacy Can Address and Impact Social Determinants of Health
Social determinants of health can become barriers to patients receiving adequate health care and are drivers of most health outcomes.